MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy

This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering…

Arcus Biosciences Stock May Be The Next To Fail (NYSE:RCUS)

This article was written by Follow At ELAM1, we empower financial professionals and investors with the…

Ideaya Biosciences: Value Beyond Darovasertib With ADC Program IDE849 (NASDAQ:IDYA)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company…

Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET Company…

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM…

Why Cytek Biosciences Stock Should Beat Q1 Earnings Expectations (NASDAQ:CTKB)

This article was written by Follow Oakoff Investments is a personal portfolio manager and a quantitative…

How Colossal Biosciences is attempting to own the “woolly mammoth”

Revive & Restore, a de-extinction organization in Sausalito, California, that is working toward reviving the passenger…

Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?

On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire…